-
Ketamine therapy can help people with depression, but also requires professional supervision to mitigate risks.
Medical Mythbusting Commentary for August 22, 2024 Source:Ketamine therapy can help people with depression, but also poses risks: experts
-
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.
Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
-
Scalp cooling therapy: The Ottawa Hospital could lose technology that helps prevent hair loss in cancer patients.
Medical Mythbusting Commentary for July 3, 2024 Source:Scalp cooling therapy: The Ottawa Hospital could lose technology that helps prevent hair loss in cancer patients
-
World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says. Indicated for type 2 diabetes management. Expensive and utility remains uncertain.
Medical Mythbusting Commentary for June 18, 2024 Source:World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
-
FDA approves new drug to treat pulmonary arterial hypertension
Medical Mythbusting Commentary for March 28, 2024 Source:FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time bomb’ Reference:Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
-
A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease
Medical Mythbusting Commentary for March 18, 2024 Source:A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease
-
FDA approves first treatment for severe frostbite
Medical Mythbusting Commentary for February 16, 2024 Source:FDA approves first treatment for severe frostbite